(6-Bromobenzo[d][1,3]dioxol-5-yl)methanol, 95.0%, 5g

2-BROMO-6-CHLORO-4-(TRIFLUOROMETHYL)BENZOIC ACID, 95.0%, 500mg

(1R,7R)-4-Dimethylamino-9,9-dimethyl-2,2,6,6-tetrakis(3,5-dimethylphenyl)-3,5,8,10-tetraoxa-4-phosphabicyclo[5.3.0]decane, 95%, 1g

Dimethyl n-methylsulfamide, 97.0%, 25g

5-(Thiazol-2-yl)isoxazole-3-carboxylic acid, 95.0%, 1g

4-Bromo-3-fluorophenylacetic acid, 97.0%, 1g

Acetophenone O-Benzoyloxime>98.0%(HPLC)(N)1g

Eau PCR, 30 ml, 20 x 1,5 ml en tubes

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid, 95.0%, 100mg

7-Bromo-2-tetralone, 95.0%, 250mg

2,5-Dichloropyridine 1-oxide, 95.0%, 1g

2-Bromoethyl ethyl ether (stabilised with Potassium Carbonate), 90.0%, 5g

Pyrido[4,3-d]pyrimidin-5(6H)-one, 8-bromo-2-[(1-methyl-4-piperidinyl)amino]-4-[(4-phenoxyphenyl)amino]-, 100mg